Although antiretroviral therapy can hold HIV in check and prevent progression to AIDS, many people living with the virus still develop neurological problems. These complications, collectively known as neuroHIV, arise when HIV infection disrupts the structure and function of the nervous system. According to Medical Xpress, researchers are investigating the underlying mechanisms rather than treating neuroHIV as a simple consequence of viral load.
The new work focuses on a specific protein that may drive brain damage in neuroHIV. The report suggests this protein plays a role in the functional and structural changes seen in the brain during HIV infection. The available excerpt does not name the protein, so its precise identity and the experimental evidence behind the claim are not detailed here.
Still, the finding matters because it offers a more targeted way to think about neuroHIV. If the protein is confirmed as a driver of damage, it could become a therapeutic target for protecting the brain in people living with HIV, even when antiretroviral drugs are working.